Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio?

Zinger Key Points

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

  1. Webull Corporation BULL shares escalated 119.05%. The stock debuted on the Nasdaq earlier last week.
  2. Hertz Global Holdings Inc HTZ shares skyrocketed 99.03% after Bill Ackman’s Pershing Square Capital Management filed an amended 13F showing that the firm purchased 12.71 million shares of the rental car company as of Dec. 31, representing a stake of approximately 4.1%.
  3. Metsera, Inc. MTSR stock is jumping 49.62% after Pfizer, Inc. PFE discontinued the development of danuglipron.
  4. Vista Energy VIST shares surged 35.52% after the company announced it acquired Petronas E&P Argentina through a mixed transaction consisting of $900 million in cash, $300 million in deferred payments, and approximately 7.3 million ADS units.
  5. Certara, Inc. CERT stock upped 34.63% after the company issued a year-over-year increase in its first-quarter revenue guidance and announced a $100 million share repurchase program. Additionally, the company announced it launched a non-animal navigator solution to help drug developers reduce reliance on animal testing.
  6. Sibanye-Stillwater SBSW shares 27.76%, probably amid a rally in the value of the commodity past the price of $3300 and towards an all-time high.
  7. Banco Macro BMA stock increased 27.71%.

Photo by via Shutterstock

Got Questions? Ask
Which mid-cap stocks could keep gaining momentum?
How will Hertz Global perform after Ackman's investment?
What impact might Webull's debut have on tech investments?
Are there opportunities in rental car stocks like Hertz?
How could Vista Energy's acquisition affect its stock price?
Will Certara's revenue increase drive more investor interest?
What does Sibanye-Stillwater's rally mean for commodity investors?
Could Banco Macro's growth signal a trend for Latin American banks?
Are there potential risks with Pfizer's discontinued projects?
How might other mid-cap companies capitalize on the current trends?
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...